Clinical Trial Update: To Evaluate Effectiveness of Aclidinium Bromide/Formoterol Fumarate Dihydrate in Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the fixed-dose combination of aclidinium bromide and formoterol fumarate dihydrate for chronic obstructive pulmonary disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aclidinium bromide/formoterol fumarate dihydrate (Aclidinium bromide/formoterol fumarate dihydrate)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: WITHDRAWN